$NVAX 8-K/A SEC Filings

Filed On	Filing
02 Nov 2023	8-K/A: Submission of Matters to a Vote of Security Holders Consistent with the recommendation of the Company’s Board of Directors (the “Board”) as set forth in the Company’s proxy statement with respect to the 2023 Annual Meeting, a majority of votes at the 2023 Annual Meeting were cast in favor...
09 Dec 2022	8-K/A: Departure/Election of Directors or Officers; Compensation On November 1, 2022, Novavax, Inc. (the “Company”) filed a Current Report on Form 8-K reporting that the Company’s Board of Directors (the “Board”) had appointed Richard J. Rodgers to the Board. At the time of the filing, the Board had n...
16 Dec 2020	8-K/A: Departure/Election of Directors or Officers; Compensation
10 Aug 2020	8-K/A: Completion of Acquisition or Disposition of Assets
07 May 2014	8-K/A: Changes in Registrant's Certifying Accountant
02 May 2014	8-K/A: Changes in Registrant's Certifying Accountant
09 Jul 2007	8-K/A: Entry into a Material Definitive Agreement
14 Nov 2006	8-K/A: Financial Statements and Exhibits
09 Aug 2005	8-K/A: Results of Operations and Financial Condition
14 Mar 2005	8-K/A: Departure/Election of Directors or Officers; Compensation
04 Nov 2004	8-K/A: Departure/Election of Directors or Officers; Compensation
23 Mar 2001	8-K/A: Financial Statements and Exhibits
21 Dec 2000	8-K/A: Completion of Acquisition or Disposition of Assets
18 Dec 2000	8-K/A: Financial Statements and Exhibits
18 Oct 1999	8-K/A: Financial Statements and Exhibits

Comments